Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Clinical protocol for phase I/II testing of tgAAV-CFTR

June 5, 1998

Zyrtec approved for use in children as young as two years

June 5, 1998

Neurokinin antagonists in the pipeline at Schering-Plough

June 4, 1998

Byk Gulden's new PDE IV inhibitors

June 4, 1998

AxyS files IND for dry powder inhalation formulation of APC-366

June 4, 1998

Nikken Chemicals presents new antiasthmatic agents

June 3, 1998

New lipoxygenase inhibitors for asthma and other inflammatory conditions

June 2, 1998

New tachykinin antagonists patented by Pfizer

May 29, 1998

Neurokinin antagonists for bronchoconstriction, neurogenic inflammation

May 29, 1998

Multiple-dose pharmacokinetics/pharmacodynamics reported for ABT-761

May 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...